The Ladies First Library

Learn: straight answers about GLP-1 weight care

Weight care comes with a lot of questions — and a lot of internet noise. This library exists to answer the real ones in plain language: how these medications work, what the research actually showed, what side effects feel like, what things cost, and what happens when you stop. Everything here is general education, written honestly — including the parts other sites skip. The decisions about your care are always made by a medical provider licensed in your state.

Free 3-minute check · No payment until a medical provider approves your plan · 100% self-pay · Cancel any time

A woman reading in a sunlit window nook

Cost & Coverage

What insurance does and doesn’t do for weight-loss medication, and what transparent self-pay pricing looks like.

Want the short version?

Our FAQ answers 55 of the most common questions — pricing, shipping, billing, switching, side effects — in a few sentences each. Start there, come back here when you want the full picture.

Browse the FAQ →

Reading is a good start. A real answer is better.

Every article here ends the same honest way: whether GLP-1 treatment is appropriate for you is a medical decision, made by a licensed provider who has reviewed your actual health history — not a blog post. Finding out takes about 3 minutes, costs nothing, and you’re never charged unless a provider approves your plan.

See If You Qualify

Free 3-minute check · Provider review usually within 48 hours · Cancel any time

Ladies First is a women’s telehealth platform and does not provide medical services. All medical care is provided by our medical provider partner, an independent network of US-licensed medical providers; all medical decisions are made by a medical provider licensed in your state. Compounded preparations of semaglutide and tirzepatide are not FDA-approved for this specific formulation; they are dispensed by state-licensed compounding pharmacies operating under USP <795> and/or USP <797> standards. Individual results vary. Clinical trial data referenced applies to the FDA-approved branded products. Ozempic® and Wegovy® are registered trademarks of Novo Nordisk A/S; Mounjaro® and Zepbound® are registered trademarks of Eli Lilly and Company; neither is affiliated with Ladies First. This page is general information, not medical advice. 100% self-pay.